What we do Biofil Chemicals & Pharmaceuticals Ltd manufactures pharmaceutical formulations and chemical products, providing job work and packaging solutions primarily from its units in Madhya Pradesh, India. |
Founded in 1,985 |
Market share A notable Indian player in pharmaceutical formulations and chemical sectors with steady regional presence. |
Problem solved Supports pharma companies with manufacturing and packaging solutions, ensuring supply of quality formulations and chemical products. |
Top clients or who we serve B2B pharma companies; partners include government undertakings like HLL Lifecare Limited for specialty drug manufacturing. |
Key management Mr. Ketan Shah, Chairman and Managing Director, leads with extensive industry experience and strategic vision. |
Our journey and innovations Founded in 1985, expanded via rights issue in 1996; diversified into bulk drugs, formulations, and plastic packaging, and partnered with HLL Lifecare. |
Where we operate Operations centered in Madhya Pradesh with domestic market focus and strategic tie-ups with government entities. |
Top products or what we offer Pharmaceutical formulations such as injections, capsules, eye-drops, dry syrups; chemical products; and plastic packaging solutions. |
Top brands No specific flagship brands publicly reported; key revenue drivers include Pharma and Chemicals divisions. |
Raw materials needed Active pharmaceutical ingredients, chemicals, polymers for plastic packaging. |
Raw materials supplier Supplied by Indian chemical and pharma raw material vendors (details not specified). |
Recurring vs cyclical contribution Revenue comprises recurring manufacturing contracts and project-based chemical sales. |
Our industry position Mid-tier manufacturer with niche in contract manufacturing and pharma packaging in India. |
Financial highlights FY 2024-25 revenue at INR 33.4 crore, net profit INR 0.56 crore, reflecting moderate scale and profitability. |
Geographical revenue split Primarily domestic Indian markets; no explicit international presence mentioned. |
Order book - |
Whats driving growth Capacity upgrades, regulatory compliance improvements, and strategic asset monetization drive growth potential. |
Our future plans Plan to sell vacant land portion to fund capacity modernization and boost operational efficiency. |
Our green promise Committed to energy conservation and environment-friendly operations; no capital investments yet for green tech. |
Our people and values Professional Board with a blend of executive and independent directors fostering governance and ethical practices. |
Key challenges ahead Regulatory delays, operational constraints, and high investment needs for capacity utilization. |
Interesting facts Entered partnership with government entity HLL Lifecare Ltd for manufacturing essential pharma products. |
Risks and strategy Mitigates risks via asset monetization and modernization plans while maintaining compliance and governance. |
